Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs

Nature Neuroscience

Volumn 4, Issue 3, 2001, Pages 268-274

  King, Michael ^a   Su, Wendy ^b   Chang, Albert ^a   Zuckerman, Amy ^a   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLYCOPROTEIN P; IODINE 125; MESSENGER RNA; MORPHINE; NALTREXONE; NEUROTRANSMITTER;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TOLERANCE; DRUG TRANSPORT; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIL FLICK TEST;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BETA-ENDORPHIN; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; DOWN-REGULATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; MICE; MICE, KNOCKOUT; MORPHINE; NARCOTICS; P-GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0035118510     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/85115     Document Type: Article

References (50)

1. Mediation of anorexia by human, recombinant tumor necrosis factor through a peripheral action in the rat
2. Elevation of tumor necrosis factor in head injury
3. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats
4. Saturable transport of peptides across the blood-brain barrier
5. 2(Tyr-W-MIF-I) is transported from the brain to the blood by peptide transport system-I
6. Passage of peptides across the blood-brain barrier: Pathophysiological perspectives
7. Increased brain P-glycoprotein in morphine tolerant rats
8. 2.5] enkephalin by P-glycoprotein modulation
9. 2.5] enkephalin across the blood-brain barrier involves transcytosis
10. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side effects of asimadoline, a peripherally acting analgaesic drug
11. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat
12. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
13. The role of P-glycoprotein in blood-brain barrier transport of morphine: Transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+)mice
14. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-barrier sites
15. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain
16. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, diagoxin and cyclosporin A
17. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein
18. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells
19. 2.5] enkephalin in mdr1a-gene-deficient mice
20. Functional involvement of P-glycoprotein in blood-brain barrier
21. Multidrug resistance and the role of P-glycoprotein knockout mice
22. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
23. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells
24. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor
25. 3-related opioid receptor
26. Antisense oligodeoxynucleotides to the cloned δ receptor, DOR-I: Uptake, stability and regulation of gene expression
27. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein α subunits
28. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance
29. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells
30. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides
31. - current and volume regulation in bovine ciliary epithelial cells
32. Genetic analysis of the multidrug transporter
33. Topical opioids in mice: Analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist
34. Peripheral morphine analgesia: Synergy with central sites and a target of morphine tolerance
35. Brain microvascular and astrocyte localization of P-glycoprotein
36. Tolerance to morphine analgesia: Decreased multiplicative interaction between spinal and supraspinal sites
37. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain
38. Dissociation of affinity and efficacy in KOR-3 chimeras
39. μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla
40. Synergistic brainstem interactions for morphine analgesia
41. Separation of opioid analgesia from respiratory depression: Evidence for different receptor mechanisms
42. Dissociation of morphine's analgesic and respiratory depressant actions
43. 3-related opioid receptor using antisense oligodeoxynucleotides
44. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine
45. Pharmacological characterization of orphanin FQ/nociceptin and its fragments
46. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia
47. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments
48. Peripheral blockade of topical morphine tolerance by ketamine